Both in Pharmaceuticals
Unicycive Therapeutics vs NRX Pharmaceuticals
Over the past year UNCY returned +9.6% and NRXP returned −10.2%; their daily moves had a correlation of 0.07.
UNCY +9.6% NRXP −10.2%Growth of $1, one year, split-adjusted
| Metric | UNCY | NRXP |
|---|---|---|
| Price | $4.55 | $2.92 |
| Market cap | $126.7M | $126.4M |
| Today | −1.94% | +1.74% |
| 1 month | −13.6% | −17.7% |
| 6 months | −25.5% | +39.7% |
| Year to date | −21.1% | +7.7% |
| 1 year | +13.2% | −1.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 38.7% |
| Net margin | — | −1500.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 37.2× |
| Net cash | $61.4M | $26.3M |
| Dividend yield | — | — |
| Volatility (60d) | 52.4% | 66.1% |
| Short % of float | 15.6% | 31.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).